{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:12Z","timestamp":1790188272556,"version":"4.1.0"},"reference-count":23,"publisher":"Hindawi Limited","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":716,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/ijcp.12213","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T16:40:11Z","timestamp":1381250411000},"page":"1238-1246","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapy"],"prefix":"10.1155","volume":"67","author":[{"given":"T.","family":"Rhodes","sequence":"first","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Epidemiology; North Wales PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Norquist","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Epidemiology; North Wales PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. McCrary","family":"Sisk","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Global Scientific & Medical Publications; Rahway NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"McQuarrie","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Epidemiology; North Wales PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trovato","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Clinical and Quantitative Sciences; Rahway NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Liao","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Epidemiology; North Wales PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Miller","sequence":"additional","affiliation":[{"name":"Quintiles Strategic Research & Safety; Research Triangle Park NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Maccubbin","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Clinical and Quantitative Sciences; Rahway NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Watson","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme Corp.; Epidemiology; North Wales PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,9,15]]},"reference":[{"key":"10.1111\/ijcp.12213-BIB0001|ijcp12213-cit-0001","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","author":"Third report of the National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12213-BIB0002|ijcp12213-cit-0002","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The framingham study","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12213-BIB0003|ijcp12213-cit-0003","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11883-000-0093-1","article-title":"Mechanism of action of niacin on lipoprotein metabolism","volume":"2","author":"Kamanna","year":"2000","journal-title":"Curr Atheroscler Rep"},{"key":"10.1111\/ijcp.12213-BIB0004|ijcp12213-cit-0004","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.amjcard.2007.09.080","article-title":"Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?","volume":"100","author":"Kamanna","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12213-BIB0005|ijcp12213-cit-0005","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/j.amjcard.2008.02.029","article-title":"Mechanism of action of niacin","volume":"101","author":"Kamanna","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12213-BIB0006|ijcp12213-cit-0006","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1972.03200210062030","article-title":"The coronary drug project","volume":"221","year":"1972","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12213-BIB0007|ijcp12213-cit-0007","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12213-BIB0008|ijcp12213-cit-0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1749-6632.1994.tb17337.x","article-title":"Types of change in coronary stenosis severity and their relative importance in overall progression and regression in coronary disease. Observations from the FATS trial. Familial Atherosclerosis Treatment study","volume":"748","author":"Brown","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/ijcp.12213-BIB0009|ijcp12213-cit-0009","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","author":"The Coronary Drug Project Research Group","year":"1975","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12213-BIB0010|ijcp12213-cit-0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12213-BIB0011|ijcp12213-cit-0011","first-page":"2255","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"24","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12213-BIB0012|ijcp12213-cit-0012","unstructured":"Armitage J on behalf of the HPS2-THRIVE Collaborative Group HPS2-THRIVE. Randomized placebo-controlled trial of extended-release niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease 2013"},{"key":"10.1111\/ijcp.12213-BIB0013|ijcp12213-cit-0013","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0026-0495(85)90092-7","article-title":"Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin","volume":"34","author":"Knopp","year":"1985","journal-title":"Metabolism"},{"key":"10.1111\/ijcp.12213-BIB0014|ijcp12213-cit-0014","first-page":"229","article-title":"Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice","volume":"62","author":"Birjmohun","year":"2004","journal-title":"Neth J Med"},{"key":"10.1111\/ijcp.12213-BIB0015|ijcp12213-cit-0015","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archinte.1994.00420140051007","article-title":"Comparative effects of lovastatin and niacin in primary hypercholesterolemia: a prospective trial","volume":"154","author":"Illingworth","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.12213-BIB0016|ijcp12213-cit-0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6904-3-4","article-title":"The safety of over-the-counter niacin. A randomized placebo-controlled trial","volume":"3","author":"Mills","year":"2003","journal-title":"BMC Clin Pharmacol"},{"key":"10.1111\/ijcp.12213-BIB0017|ijcp12213-cit-0017","unstructured":"Abbott Laboratories NIASPAN\u2122 (niacin extended_release tables) US prescribing informaion http:\/\/www.rxabbvie.com\/pdf\/niaspan.pdf"},{"key":"10.1111\/ijcp.12213-BIB0018|ijcp12213-cit-0018","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1185\/03007990802083408","article-title":"Dosage, titration, and gaps in treatment with extended release niacin in clinical practice","volume":"24","author":"Kamal-Bahl","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/ijcp.12213-BIB0019|ijcp12213-cit-0019","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2006.08.063","article-title":"Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice","volume":"99","author":"Kamal-Bahl","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12213-BIB0020|ijcp12213-cit-0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1185\/030079907X199637","article-title":"Development and validation of a questionnaire to assess niacin-induced cutaneous flushing'","volume":"23","author":"Norquist","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/ijcp.12213-BIB0021|ijcp12213-cit-0021","unstructured":"Norquist JM Mehta V McQuarrie KA Development and Validation of a Questionnaire to Assess the Impact of Niacin-Induced Flushing' Toronto, Canada"},{"key":"10.1111\/ijcp.12213-BIB0022|ijcp12213-cit-0022","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Out"},{"key":"10.1111\/ijcp.12213-BIB0023|ijcp12213-cit-0023","doi-asserted-by":"crossref","first-page":"35U","DOI":"10.1016\/S0002-9149(98)00952-7","article-title":"Clinical trial experience with extended-release niacin (Niaspan): Dose-escalation study","volume":"82","author":"Goldberg","year":"1998","journal-title":"Am J Cardiol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:07:16Z","timestamp":1643350036000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,15]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12213","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,15]]},"assertion":[{"value":"2013-09-15","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}